Fig. 7
From: DOCK1 regulates the malignant biological behavior of endometrial cancer through c-Raf/ERK pathway
The inhibition of DOCK1 attenuated the growth of xenograft tumors in vivo. (A-B) The images of nude mice and subcutaneous tumors at 4 weeks after injecting DOCK1-KO Ishikawa cells. (C-D) The growth and weights of tumors were analyzed in DOCK1-KO group and control group. (E) The expression of E-cadherin, MMP9, Ezrin and Bcl-2 protein on xenograft tumors by immunohistochemical assay. *P < 0.05